June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
EIOC Shares Results from IMforte Trial in Small Cell Lung Cancer
Jun 5, 2025, 11:21

EIOC Shares Results from IMforte Trial in Small Cell Lung Cancer

Excellence in Oncology Care – EIOC shared a post on X :

“Results of IMforte trial of:

Lurbinectedin + Atezolizumab as 1st line Maintenance Tx in Extensive stage Small Cell Lung Cancer.

Significant improvement in pfs hr 0.54.

Significant improvement in os hr 0.73.”

On which Alex Friedlaender, Chief resident at the Geneva University Hospitals, commented:

“The no crossover allowed part is probably limiting in a lot of countries where options are very limited… I wonder what would happen with the 3m most benefit with crossover.”

Alfredo Addeo, Chief resident at the Geneva University Hospitals, also shared his view on this:

“Tbh I don’t buy it, lurbi has yet to prove OS benefit in 2nd line.

The main limitation of the study is not allowing pts with brain mts in the study.

This is a very selected trial with very selected pts hence no widely adoptable in clinic but limited to some pts.”

EIOC Shares Results from IMforte Trial in Small Cell Lung Cancer

More posts featuring Excellence in Oncology Care.